The Center for Technology Licensing (CTL) is Cornell University's technology transfer office. We manage technology for Cornell's Ithaca campus, Weill Cornell Medicine, Cornell Tech, and Cornell AgriTech in Geneva.

Cornell Pledges to Licensing Frameworks for Rapid Utilization of COVID-19 Technologies

June 29, 2020

Cornell University is dedicated to bringing the University’s scientific discoveries, technological innovations, and medical advances to the marketplace for societal benefit. In these unprecedented times, the immediate need for innovation to help society navigate through the COVID-19 pandemic is imperative. Cornell has joined with other research universities and the Association of University Technology Managers (AUTM) and pledged to the following frameworks to help meet this crucial challenge.


COVID-19 Technology Access Framework

The first is the COVID-19 Technology Access Framework. Led by founding institutions Harvard University, Massachusetts Institute of Technology, Stanford University, Cornell University and many more prestigious institutions have committed to a technology transfer framework to enable rapid utilization of discoveries that may play a role in preventing, diagnosing and treating COVID-19 infection during the pandemic.


More information on the COVID-19 Technology Access Framework here.


AUTM’s COVID-19 Licensing Guidelines

The second initiative is joining with AUTM’s COVID-19 Licensing Guidelines. The AUTM COVID-19 Licensing Guidelines enable and empower technology transfer offices from university and other non-profit research organizations to facilitate a rapid response to the COVID-19 pandemic.


More information on AUTM’s COVID-19 Licensing Guidelines here.